标题
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
作者
关键词
-
出版物
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-12-11
DOI
10.1002/eji.202048992
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells
- (2020) Kazushige Yoshida et al. BMC CANCER
- Colon carcinoma treatment using bispecific anti-GITR/CTLA-4 antibodies: a patent evaluation of WO2018091739
- (2020) Lourdes Millán-Pérez Peña et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target
- (2020) Zachary T. Freeman et al. JOURNAL OF CLINICAL INVESTIGATION
- Multispecific drugs herald a new era of biopharmaceutical innovation
- (2020) Raymond J. Deshaies NATURE
- CRISPR screen in regulatory T cells reveals modulators of Foxp3
- (2020) Jessica T. Cortez et al. NATURE
- The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth
- (2020) Siqi Chen et al. Cancer Immunology Research
- Robust intrathymic development of regulatory T cells in young NOD mice is rapidly restrained by recirculating cells
- (2020) Julie Darrigues et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Regulatory t cell metabolism at the intersection between autoimmune diseases and cancer
- (2020) Henry Kurniawan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity
- (2020) Francesca Zammarchi et al. Journal for ImmunoTherapy of Cancer
- Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity
- (2019) Masanori Onda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?
- (2019) Yoshihiro Ohue et al. CANCER SCIENCE
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody
- (2019) Tao Dao et al. OncoImmunology
- The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
- (2019) Anne Månsson Kvarnhammar et al. Journal for ImmunoTherapy of Cancer
- Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Response
- (2019) Anu Sharma et al. CLINICAL CANCER RESEARCH
- Targeting Treg cells in cancer immunotherapy
- (2019) Atsushi Tanaka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Pivotal Role of Regulatory T Cells in the Regulation of Innate Immune Cells
- (2019) Emeka B. Okeke et al. Frontiers in Immunology
- The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy
- (2019) Ryuhei Okada et al. BIOCONJUGATE CHEMISTRY
- Next-generation regulatory T cell therapy
- (2019) Leonardo M. R. Ferreira et al. NATURE REVIEWS DRUG DISCOVERY
- T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
- (2019) Christina M. Paluskievicz et al. Frontiers in Immunology
- Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
- (2018) David Wang et al. Cell Reports
- Abstract LB-153: KY1055, a novel ICOS-PD-L1 bispecific antibody, efficiently enhances T cell activation and delivers a potent anti-tumour response in vivo
- (2018) Richard C. Sainson et al. CANCER RESEARCH
- Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
- (2018) Sangeeta Goswami et al. JOURNAL OF CLINICAL INVESTIGATION
- Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
- (2018) Karie Runcie et al. MOLECULAR MEDICINE
- Antigen-Specificity in the Thymic Development and Peripheral Activity of CD4+FOXP3+ T Regulatory Cells
- (2018) Jelka Pohar et al. Frontiers in Immunology
- Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function
- (2018) Sarah L. Buchan et al. IMMUNITY
- Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
- (2018) Kevin Sek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity
- (2018) Chien-Chun Steven Pai et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
- (2018) Danbee Ha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types
- (2018) Angela M. Magnuson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How Does an Anti-CTLA-4 Antibody Promote Cancer Immunity?
- (2018) Yang Liu et al. TRENDS IN IMMUNOLOGY
- Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment
- (2018) Yasuko Tada et al. Journal for ImmunoTherapy of Cancer
- Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers
- (2018) Takefumi Komiya et al. Frontiers in Oncology
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
- (2017) Frederick Arce Vargas et al. IMMUNITY
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- CCR8+FOXp3+Tregcells as master drivers of immune regulation
- (2017) Yiftah Barsheshet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis
- (2017) Luigi Cari et al. OncoImmunology
- Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy
- (2016) Ashley E. Mahne et al. CANCER RESEARCH
- Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
- (2016) Marco De Simone et al. IMMUNITY
- Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity
- (2016) Hidetoshi Nakagawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy
- (2016) Kazuhide Sato et al. Science Translational Medicine
- Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients
- (2015) K. Kurose et al. CLINICAL CANCER RESEARCH
- The Chromatin-Modifying Enzyme Ezh2 Is Critical for the Maintenance of Regulatory T Cell Identity after Activation
- (2015) Michel DuPage et al. IMMUNITY
- Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- (2014) Khaled Ali et al. NATURE
- Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
- (2014) A. Young et al. Cancer Discovery
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis
- (2013) Greg M. Delgoffe et al. NATURE
- T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development
- (2012) Naganari Ohkura et al. IMMUNITY
- Impact of Basiliximab on the Proportion of Regulatory T Cells and Their Subsets Early After Renal Transplantation: A Preliminary Report
- (2012) T. Zhao et al. TRANSPLANTATION PROCEEDINGS
- Molecular Mechanisms of Treg-Mediated T Cell Suppression
- (2012) Angelika Schmidt et al. Frontiers in Immunology
- Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
- (2012) Helene Pere et al. OncoImmunology
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions
- (2010) Stefania Laurent et al. HUMAN IMMUNOLOGY
- Regulatory T cells in tumor immunity
- (2010) Hiroyoshi Nishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- CD4+CD25+ Treg cells inhibit human memory T cells to produce IFN- in response to M tuberculosis antigen ESAT-6
- (2008) L. Li et al. BLOOD
- Contribution of CCR4 and CCR8 to antigen-specific TH2 cell trafficking in allergic pulmonary inflammation
- (2008) Zamaneh Mikhak et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment
- (2008) Lawrence Fong et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now